Table 1 Baseline characteristics of the research patients (n = 117)
General information | Data |
|---|---|
Age(y) | 60 ± 10 |
Sex [n (%)] | |
Male | 96 (82.1%) |
Female | 21 (17.9%) |
Operation mode [n (%)] | |
RFA + TACE | 38 (32.5%) |
MWA + TACE | 79 (67.5%) |
Hepatectomy before treatment [n (%)] | |
Yes | 25 (21.4%) |
No | 92 (78.6%) |
Hepatitis [n (%)] | |
HBV | 102 (87.2%) |
HCV | 4 (3.4%) |
Cirrhosis [n (%)] | |
yes | 80 (68.4%) |
no | 37 (31.6%) |
ALB(g/l) | 40.0 ± 5.0 |
AFP (ng/ml) | 497.5 ± 1776.8 |
AST/ALT ratio | 1.3 ± 1.3 |
Tumor numbers | |
1 | 68 (58.1%) |
2 | 18 (15.4%) |
≥ 3 | 31 (26.5%) |
Tumor maximum diameter(mm) | 27.7 ± 12.9 |
BCLC stages | |
A | 86 (73.5%) |
B | 31 (26.5%) |
Child–Pugh grades | |
A | 113 (96.6%) |
B | 4(3.4%) |